New Weight Loss Pill: FDA Greenlights Oral GLP-1, “Foundayo”
The weight loss landscape has dramatically shifted with the FDA’s approval of Eli Lilly’s oral GLP-1 medication, “Foundayo.” This marks a significant advancement in the accessibility and convenience of this revolutionary class of drugs, potentially transforming obesity care on a…










